Tuesday, March 12, 2013 12:30:21 PM
short interest up by 500,000
y March 12, 2013 20 Min Delayed
Short Quote™
Enter Symbol:
Delcath Systems Incorporated
$ 1.99
DCTH
-0.14
Daily Short Sale Volume
view
Short Interest (Shares Short)
7,569,100
Days To Cover (Short Interest Ratio)
5.5
Short Percent of Float
10.25 %
Short Interest - Prior
7,090,200
Short % Increase / Decrease
6.75
Daily Naked Short Selling List
view
Short Squeeze Ranking™
view
% From 52-Wk High ($ 3.61 )
-44.88%
% From 52-Wk Low ($ 1.01 )
97.03%
% From 200-Day MA ($ 1.74 )
14.37%
% From 50-Day MA ($ 1.51 )
31.79%
Price % Change (52-Week)
-43.47%
Shares Float
73,880,000
% Owned by Insiders
2.26%
% Owned by Institutions
16.50%
Market Cap.
$ 159,000,000
Trading Volume - Today
3,476,742
Trading Volume - Average
1,382,000
Trading Volume - Today vs. Average
251.57%
Earnings Per Share
-1.03
PE Ratio
0.00
Record Date
2013-MarA
Sector
Healthcare
Industry
Drug Delivery
Exchange
NAS
y March 12, 2013 20 Min Delayed
Short Quote™
Enter Symbol:
Delcath Systems Incorporated
$ 1.99
DCTH
-0.14
Daily Short Sale Volume
view
Short Interest (Shares Short)
7,569,100
Days To Cover (Short Interest Ratio)
5.5
Short Percent of Float
10.25 %
Short Interest - Prior
7,090,200
Short % Increase / Decrease
6.75
Daily Naked Short Selling List
view
Short Squeeze Ranking™
view
% From 52-Wk High ($ 3.61 )
-44.88%
% From 52-Wk Low ($ 1.01 )
97.03%
% From 200-Day MA ($ 1.74 )
14.37%
% From 50-Day MA ($ 1.51 )
31.79%
Price % Change (52-Week)
-43.47%
Shares Float
73,880,000
% Owned by Insiders
2.26%
% Owned by Institutions
16.50%
Market Cap.
$ 159,000,000
Trading Volume - Today
3,476,742
Trading Volume - Average
1,382,000
Trading Volume - Today vs. Average
251.57%
Earnings Per Share
-1.03
PE Ratio
0.00
Record Date
2013-MarA
Sector
Healthcare
Industry
Drug Delivery
Exchange
NAS
Recent DCTH News
- Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 05/15/2026 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 09:47:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 09:45:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 09:45:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 09:45:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 09:45:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2026 12:23:52 PM
- Delcath Systems to Participate at the H.C. Wainwright 4th Annual BioConnect Investor Conference • Business Wire • 05/12/2026 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 01:09:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 12:12:12 PM
- Delcath Systems Reports First Quarter 2026 Results and Business Highlights • Business Wire • 05/07/2026 12:00:00 PM
- Delcath Systems Announces Presentation of New Data on Percutaneous Hepatic Perfusion with Melphalan in Liver-Dominant Metastatic Breast Cancer at ESMO Breast Cancer 2026 • Business Wire • 05/07/2026 11:00:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/27/2026 08:12:24 PM
- Delcath Systems to Host First Quarter 2026 Earnings Call • Business Wire • 04/23/2026 12:30:00 PM
- Delcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the ESMO–EURACAN Clinical Practice Guidelines for Uveal Melanoma • Business Wire • 04/06/2026 12:30:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/02/2026 12:56:15 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/02/2026 12:55:31 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/02/2026 12:52:52 PM
- Delcath Systems to Participate at the Society of Interventional Radiology 2026 Meeting • Business Wire • 04/01/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 09:22:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 09:48:16 PM
- Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology • Business Wire • 03/03/2026 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2026 02:15:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 01:06:06 PM
